A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection.

Trial Profile

A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2009

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriatic arthritis
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 16 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Actual patient number (93) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top